IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,529,519 | +32.1% | 96,378 | +57.1% | 0.01% | +20.0% |
| Q2 2023 | $1,157,995 | +1021.7% | 61,367 | +128.3% | 0.01% | – |
| Q1 2023 | $103,238 | -23.8% | 26,885 | -1.5% | 0.00% | -100.0% |
| Q4 2022 | $135,448 | +1405.0% | 27,308 | +1254.6% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 2,016 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -33.3% | 2,016 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | +36.4% | 2,016 | +7.9% | 0.00% | – |
| Q3 2021 | $11,000 | +120.0% | 1,868 | +150.4% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 746 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +200.0% | 746 | +200.8% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 248 | -54.7% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 548 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 548 | +22.3% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 448 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 448 | +31.8% | 0.00% | – |
| Q1 2019 | $1,000 | – | 340 | +407.5% | 0.00% | – |
| Q4 2017 | $0 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |